Tibet Duo Rui Pharmaceutical (301075.SZ) plans to establish Tibet Ruishengxiang Pharmaceutical Co., Ltd.
Duo Rui Pharmaceuticals (301075.SZ) announced that, according to the company's operating and strategic development needs, in order to optimize the company's overall...
Tibet Duo Rui Pharmaceutical (301075.SZ) announced that, for the optimization of the company's headquarters management functions and strategic development needs, the company has established a wholly-owned subsidiary, Tibet Ruishengxiang Pharmaceutical Co., Ltd., with a registered capital of 2 million yuan.
Related Articles
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Guosen: RWA welcomes the era of strict supervision.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Guosen: RWA welcomes the era of strict supervision.
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
